Immune responses against tetracycline‐dependent transactivators affect long‐term expression of mouse erythropoietin delivered by a helper‐dependent adenoviral vector
Abstract
Background Helper-dependent adenoviral (HD-Ad) vectors give rise to sustained gene expression after delivery in a variety of organisms. In particular, we previously documented persistent expression of erythropoietin (EPO) in mice after a single intramuscular (i.m.) injection of a HD-Ad vector harboring the mouse EPO cDNA. Methods We use the same vector harboring the tetracycline (tet)-dependent transactivator (rtTA2S-M2) and silencer (tTS) and mouse EPO cDNA to analyze the capacity of the dual tet-dependent transactivator system to control long-term EPO gene expression and to study the effect of an eventual immune response against these artificial proteins after i.m. delivery in immuno-competent mice. Results In the present study we demonstrate that i.m. injection of this vector in immuno-competent mice generates a cellular immune response to the rtTA2S-M2 transcription factor. This response curtails the duration of mouse EPO expression in mice, presumably by destroying the cells that co-express transcription factors and the therapeutic gene. Nonetheless, regulation of mouse EPO secretion was maintained during the entire experimental period, both when the vector dosage was reduced and when the tet-dependent transcription factors were put under the control of a muscle-specific promoter. Conclusions Delivery of the tet transactivators using as vehicle a HD-Ad vector induced an immune response directed against the transactivators themselves, causing short-term therapeutic transg…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In vivo application of the Tet-On systems can be complicated by immune responses against rtTA, as reported in rodents and non-human primates.
“In vivo application of the systems can be complicated by immune responses against rtTA, as reported in rodents and non-human primates [73-78].”
From Tet-On Systems For Doxycycline-inducible Gene Expression (2016) · cites this paper as [74]
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · see citing works
Transcriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488 · see citing works
Cordier, L., Gao, G.-P., Hack, A. A., McNally, E. M., Wilson, J. M., Chirmule, N., & Sweeney, H. L. (2001) · Human Gene Therapy · doi:10.1089/104303401750061267 · Cited by 152 · see citing works
Favre, D., Blouin, V., Provost, N., Spisek, R., Porrot, F., Bohl, D., Marmé, F., Chérel, Y., Salvetti, A., Hurtrel, B., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11605-11611.2002 · Cited by 150 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Tet-On Systems For Doxycycline-inducible Gene Expression
T. Das, A., Tenenbaum, L., & Berkhout, B. (2016) · Current Gene Therapy · doi:10.2174/1566523216666160524144041 · Cited by 434 · see citing works
“In vivo application of the systems can be complicated by immune responses against rtTA, as reported in rodents and non-human primates [73-78].”
BackgroundBarriers for retinal gene therapy: separating fact from fiction.
Kumar-Singh, R. (2008) · Vision Research · doi:10.1016/j.visres.2008.05.005 · Cited by 43 · see citing works
Markusic, D. M., de Waart, D. R., & Seppen, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009974 · Cited by 22 · see citing works
- Authors
- Lena, A. M., Giannetti, P., Sporeno, E., Ciliberto, G., & Savino, R.
- Affiliations
- Magna Graecia University (IT)
- Corresponding author
- Savino, Rocco
- Venue
- The Journal of Gene Medicine
- Publisher
- Wiley
- Published
- 2005-03-17
- Volume
- 7
- Issue
- 8
- Pages
- 1086-1096
- ISSN
- 1099-498X (ISSN-L)
- 1521-2254
- OpenAlex
- W2003665511
- Cited by
- 27
- References
- 4
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2017: 2 · 2016: 1 · 2013: 1 · 2012: 1
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Gene Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- helper-dependent adenoviral vectors, erythropoietin, cell-mediated immunity, transgene expression duration, intramuscular gene delivery, muscle-specific promoter, vector dose, immunocompetent mice, sustained gene expression
- MeSH terms
- Adenoviridae, Animals, Erythropoietin, Female, Gene Expression Regulation, Genetic Vectors, Helper Viruses, Immunity, Cellular, Mice, Inbred C57BL, Tetracycline, Time Factors, Trans-Activators, Electroporation, Muscle, Skeletal, Transgenes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review